Quoin Pharmaceuticals Statistics
NASDAQ: QNRXHealthcareBiotechnologyUSD
4.55-0.15 (-3.19%)
At close: Oct 8, 4:00 PM ET · Delayed 15 min
Quoin Pharmaceuticals by the numbers
Quoin Pharmaceuticals has a market capitalization of $21.9 million based on 4.80M shares outstanding. With trailing EPS of $-5.67, Quoin Pharmaceuticals is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 20.0% below its 50-day average and 32.9% below its 200-day average.
Average daily trading volume is 541.11K shares, or about $2.5 million in dollar volume.
Summary generated from market data by MetaCap's automated system. Methodology
QNRX valuation vs. peer median
| Metric | QNRX | Peer median | Difference |
|---|---|---|---|
| Market cap | $21.86M | $22.84M | -4% |
| Avg. volume | 541.11K | 134.39K | +303% |
Peer median across 8 companies: PLRZ, COCP, QNTM, KYNB, ATOS, ATYR, BYSI, JSPR.
Valuation
- Market cap
- $21.86M
- EPS (TTM)
- $-5.67
- Shares outstanding
- 4.80M
Price and trading
- Previous close
- 4.70
- Open
- 4.49
- Day range
- 4.30 – 4.68
- 52-week range
- 3.25 – 41.80
- 52-week change
- -44.44%
- Beta
- —
- Volume
- 48.95K
- Average volume
- 541.11K
Dividends and events
- Annual dividend
- None
- Next earnings date
- Nov 5, 2026
Additional statistics
- Market Cap
- 21.86M
- Forward Pe
- -1.43
- Eps
- -5.67
- Dividend Yield
- 0.00%
- Dividend Rate
- 0.00
- Week52 High
- 41.80
- Week52 Low
- 3.25
- Avg Volume
- 541.11K
- Shares Outstanding
- 4.80M
- Ma50
- 5.69
- Ma200
- 6.78
- Earnings Date
- Nov 5, 2026
- Pct From52w High
- -89.11%
- Pct From52w Low
- 40.00%